Analysts: Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

1,110.00
9 Jul 2014
Price Change (% chg)

-7.00₪ (-0.62%)
Prev Close
1,121.00₪
Open
1,102.00₪
Day's High
1,126.00₪
Day's Low
1,101.00₪
Volume
145,360
Avg. Vol
98,213
52-wk High
2,040.00₪
52-wk Low
1,098.00₪

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.04 December 10 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.43 2.43 2.43 2.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 5 10.97 12.40 8.51 --
Quarter Ending Dec-14 5 15.27 17.51 11.01 --
Year Ending Dec-14 5 48.87 57.00 44.00 55.38
Year Ending Dec-15 6 66.93 80.60 57.10 78.02
Earnings (per share)
Quarter Ending Sep-14 7 -0.04 0.00 -0.08 --
Quarter Ending Dec-14 7 -0.02 0.01 -0.06 --
Year Ending Dec-14 5 -0.13 -0.05 -0.24 0.04
Year Ending Dec-15 7 0.09 0.33 -0.14 0.22

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 5.70 3.57 2.13 37.38
Quarter Ending Dec-12 7.75 1.17 6.58 84.88
Quarter Ending Sep-12 2.68 3.72 1.04 38.82
Quarter Ending Jun-12 14.80 25.26 10.46 70.69
Quarter Ending Mar-12 2.13 3.86 1.74 81.65
Earnings (per share)
Quarter Ending Mar-13 -0.06 -0.05 0.01 -23.08
Quarter Ending Dec-12 -0.07 -0.11 0.04 -57.14
Quarter Ending Sep-12 -0.12 -0.06 0.06 -50.00
Quarter Ending Jun-12 -0.08 0.10 0.18 -225.00
Quarter Ending Mar-12 -0.08 -0.07 0.01 -6.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 10.97 10.97 10.97 11.42 --
Quarter Ending Dec-14 15.27 15.27 15.27 13.52 --
Year Ending Dec-14 48.87 48.87 48.87 45.90 55.38
Year Ending Dec-15 66.93 66.93 66.93 60.54 78.02
Earnings (per share)
Quarter Ending Sep-14 -0.04 -0.04 -0.04 -0.01 --
Quarter Ending Dec-14 -0.02 -0.02 -0.02 -0.00 --
Year Ending Dec-14 -0.13 -0.13 -0.13 -0.05 0.04
Year Ending Dec-15 0.09 0.09 0.09 0.14 0.22

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks